Developer of synthetic peptoid drug class intended to defend mammals against viruses without allowing viruses to develop significant resistance. The company's peptoids are highly selective for pathogens over human cells, are biostable, effective at low doses and rapidly destroys biofilm defenses, providing patients with anti-infectives against infectious pandemic microbes like untreatable viruses, drug-resistant bacteria and drug-resistant fungi.